Showing 11-20 of 30 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Expanding Access to T1D Care through the PEN-Plus Strategy | The Brigham and Women’s Hospital, Inc. | Gene Bukhman | Mission | 01-August-2024 to 31-July-2027 | $5.999.961,29 |
| Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria | Clinton Health Access Initiative (CHAI) | Margaret Prust | Mission | 01-September-2023 to 31-August-2026 | $1.702.076,57 |
| Engineered Nanobodies to Visualize and Direct Antigen-Specific Tolerance in T1D | Boston Children's Hospital | Novalia Pishesha | Cures | 01-March-2025 to 28-February-2030 | $999.999,00 |
| Integration of Slow-Release A1AT-loaded Nanoparticles for Enhanced Cell Therapy in Type 1 Diabetes | Beth Israel Deaconess Medical Center Inc | Giuseppe Pettinato | Cures | 01-October-2024 to 31-July-2026 | $200.000,00 |
| In vivo interactions and trafficking of islet antigen-specific human effector T cells and Tregs | University of Massachusetts Medical School | Michael Brehm | Cures | 01-November-2024 to 31-October-2027 | $825.000,00 |
| New lipid biomarker to predict early risk for Type 1 diabetes | Beth Israel Deaconess Medical Center Inc | Barbara Kahn | Cures | 01-September-2024 to 31-August-2027 | $899.997,53 |
| Determining the role of new genes that may be involved in Type 1 Diabetes Pathogenesis | Beth Israel Deaconess Medical Center Inc | Ismail Syed | Cures | 01-June-2024 to 31-October-2025 | $199.999,67 |
| Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes | T1D Exchange, Inc. | Nicole Rioles | Improving Lives | 01-May-2024 to 30-April-2027 | $1.995.534,06 |
| Harnessing insulin signaling in β-cells to counter type 1 diabetes | Joslin Diabetes Center Inc. | Namrata Shukla | Cures | 01-March-2024 to 28-February-2027 | $228.995,00 |
| A Nanosensor Embedded Device for Rapid Insulin Measurement | Massachusetts Institute of Technology | Michael Strano | Improving Lives | 01-April-2024 to 31-March-2027 | $600.000,00 |